Skip to content

Alinity 09P4220

by Abbott Ireland Diagnostics

Ref 09P4220

Alinity 09P4220 is a tacrolimus therapeutic drug monitoring IVD (EU IVDD general IVD; FDA Class II; FDA product code MLM, Enzyme Immunoassay, Tracrolimus) made by Abbott Ireland Diagnostics, registered in EUDAMED on 2 Nov 2026 (Basic UDI-DI B-00380740154516) and listed in FDA GUDID since 2 Jan 2020 (UDI-DI 00380740154516), active as of 7 Nov 2026.

Active European Union. Also listed in GUDID (US).

CE IVDD

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, GUDID, synced 7 Nov 2026.

Regulatory status

as of registry sync 7 Nov 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD EUDAMED NumberB-00380740154516 Basic UDI-DI 00380740154516UDI-DIDate2 Nov 2026RegisteredStatusActive
United StatesGUDID listing GUDID Number00380740154516 UDI-DI Date2 Jan 2020ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
Alinity i Tacrolimus Reagent Kit 200 Tests
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 7 Nov 2026, as the labeller entered it.

Across registries

2 registries list this device

  • EUDAMED Basic UDI-DI B-00380740154516 registered 2 Nov 2026 Active
  • FDA GUDID UDI-DI 00380740154516 listed 2 Jan 2020 Listed

Timeline

2 dated events

  1. Listed FDA GUDID 00380740154516
  2. Registered EUDAMED B-00380740154516

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDD Active
  • United States GUDID listing Listed

Specification

EUDAMED · GUDID

Trade name
Alinity
Generic name
Tacrolimus therapeutic drug monitoring IVD, kit, chemiluminescent immunoassay
Model / Ref / Catalog
09P4220
Primary DI / UDI-DI
00380740154516
Basic UDI-DI
B-00380740154516
FDA product code
MLM
EMDN code
W0102080603 Tacrolimus
GMDN term
Tacrolimus therapeutic drug monitoring IVD, kit, chemiluminescent immunoassay
Device class
Class IVD General EUDAMED
Class II GUDID
Regulation number
862.1678
EU registration type
Legacy device (under a directive)
EU market of registration
Ireland
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 1 field differs

FieldEUDAMEDGUDID
Device classEUDAMED
Class IVD General
GUDID
Class II

Device class is stated on each registry's own scale: Class IVD General in the EU (EUDAMED), Class II in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Similar devices in this category

Other devices filed under IMMUNOSUPPRESSANT TDM.

Other devices from Abbott Ireland Diagnostics

See all devices from Abbott Ireland Diagnostics →

Properties

  • Contains human tissues or cells
  • Contains animal tissues or cells
  • Reagent
  • IVD kit
  • Professional testing
  • Prescription use
  • Convenience kit
  • Lot / batch number
  • Expiration date
Other properties (17, all answered No)